Literature DB >> 22527373

Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values.

Gregor Thörmer1, Josephin Otto, Martin Reiss-Zimmermann, Matthias Seiwerts, Michael Moche, Nikita Garnov, Toni Franz, Minh Do, Jens-Uwe Stolzenburg, Lars-Christian Horn, Thomas Kahn, Harald Busse.   

Abstract

OBJECTIVES: To evaluate the influence of the choice of b values on the diagnostic value of the apparent diffusion coefficient (ADC) for detection and grading of prostate cancer (PCa).
METHODS: Forty-one patients with biopsy-proven PCa underwent endorectal 3-T MRI before prostatectomy. Different combinations of b values (0-800 s/mm(2)) were used to calculate four representative ADC maps. Mean ADCs of tumours and non-malignant tissue were determined. Tumour appearance on different ADC maps was rated by three radiologists as good, fair or poor by assigning a visual score (VS) of 2, 1 or 0, respectively. Differences in the ADC values with the choice of b values were analysed using one-way ANOVA.
RESULTS: Choice of b values had a highly (P < 0.001) significant influence on the absolute ADC in each tissue. Maps using b = [50, 800] and [0, 800] were rated best (VS= 1.6 ± 0.3) and second best (1.1 ± 0.3, P < 0.001), respectively. For low-grade carcinomas (Gleason score ≤ 6, 13/41 patients), only the former choice received scores better than fair (VS = 1.4 ± 0.3). Mean tumour ADCs showed significant negative correlation (Spearman's ρ -0.38 to -0.46, P < 0.05) with Gleason score.
CONCLUSIONS: Absolute ADC values strongly depend on the choice of b values and therefore should be used with caution for diagnostic purposes. A minimum b value greater than zero is recommended for ADC calculation to improve the visual assessment of PCa in ADC maps. KEY POINTS: • Absolute ADC values are highly dependent on the choice of b values. • Absolute ADC thresholds should be used carefully to predict tumour aggressiveness. • Subjective ratings of ADC maps involving b = 0 s/mm ( 2 ) are poor to fair. • Minimum b value greater than 0 s/mm ( 2 ) is recommended for ADC calculation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527373     DOI: 10.1007/s00330-012-2432-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features.

Authors:  M C DeLano; T G Cooper; J E Siebert; M J Potchen; K Kuppusamy
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

2.  Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate.

Authors:  P Gibbs; D J Tozer; G P Liney; L W Turnbull
Journal:  Magn Reson Med       Date:  2001-12       Impact factor: 4.668

3.  Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients.

Authors:  S F Riches; K Hawtin; E M Charles-Edwards; N M de Souza
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

4.  Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.

Authors:  Sung Yoon Park; Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee; Kyung Soo Lee
Journal:  Eur Radiol       Date:  2010-11-03       Impact factor: 5.315

5.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

Review 6.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

7.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.

Authors:  Chan Kyo Kim; Byung Kwan Park; Bohyun Kim
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

8.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.

Authors:  Thomas Hambrock; Diederik M Somford; Henkjan J Huisman; Inge M van Oort; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Thomas Scheenen; Jelle O Barentsz
Journal:  Radiology       Date:  2011-05       Impact factor: 11.105

9.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

Authors:  Anthony V D'Amico; Judd Moul; Peter R Carroll; Leon Sun; Deborah Lubeck; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

10.  High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio.

Authors:  Kazuhiro Kitajima; Yasushi Kaji; Kagayaki Kuroda; Kazuro Sugimura
Journal:  Magn Reson Med Sci       Date:  2008       Impact factor: 2.471

View more
  18 in total

1.  Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer.

Authors:  Hebert Alberto Vargas; Edward Malnor Lawrence; Yousef Mazaheri; Evis Sala
Journal:  World J Radiol       Date:  2015-08-28

2.  Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis.

Authors:  Guohua Shen; Zhiyun Jia; Houfu Deng
Journal:  Eur Radiol       Date:  2015-05-24       Impact factor: 5.315

3.  Diffusion-weighted imaging of the prostate: should we use quantitative metrics to better characterize focal lesions originating in the peripheral zone?

Authors:  Thibaut Pierre; Francois Cornud; Loïc Colléter; Frédéric Beuvon; Frantz Foissac; Nicolas B Delongchamps; Paul Legmann
Journal:  Eur Radiol       Date:  2017-11-22       Impact factor: 5.315

Review 4.  Advances in diffusion-weighted imaging.

Authors:  Lorenzo Mannelli; Stephanie Nougaret; Hebert A Vargas; Richard K G Do
Journal:  Radiol Clin North Am       Date:  2015-05       Impact factor: 2.303

5.  Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.

Authors:  Yahui Peng; Yulei Jiang; Cheng Yang; Jeremy Bancroft Brown; Tatjana Antic; Ila Sethi; Christine Schmid-Tannwald; Maryellen L Giger; Scott E Eggener; Aytekin Oto
Journal:  Radiology       Date:  2013-02-07       Impact factor: 11.105

Review 6.  The expanding landscape of diffusion-weighted MRI in prostate cancer.

Authors:  Andreas G Wibmer; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2016-05

7.  Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging.

Authors:  Osama Elbuluk; Naira Muradyan; Joanna Shih; Marcelino Bernardo; Sandeep Sankineni; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Comput Assist Tomogr       Date:  2016 Mar-Apr       Impact factor: 1.826

Review 8.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

9.  High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.

Authors:  Tsutomu Tamada; Naoki Kanomata; Teruki Sone; Yoshimasa Jo; Yoshiyuki Miyaji; Hiroki Higashi; Akira Yamamoto; Katsuyoshi Ito
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

10.  Whole-Body Diffusion-Weighted Imaging in Chronic Recurrent Multifocal Osteomyelitis in Children.

Authors:  Nadine Leclair; Gregor Thörmer; Ina Sorge; Lutz Ritter; Volker Schuster; Franz Wolfgang Hirsch
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.